Public-registry site landscape for NCT04902781, a Classic Galactosemia study sponsored by Applied Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04902781 (registry record) |
| Sponsor | Applied Therapeutics, Inc. |
| Condition(s) | Classic Galactosemia |
| Phase | PHASE2 / PHASE3 |
| Listed sites | 3 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT04902781 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →